$9.21
0.05[0.55%]
At close: Apr 26
$9.21
0[0.00%]
After Hours: 4:20PM EDT
Fennec Pharmaceuticals
(NASDAQ:FENC)Latest News for Fennec Pharmaceuticals Stock (NASDAQ:FENC)
Fennec Pharmaceuticals Stock (NASDAQ: FENC)
Categories: All
Thursday, April 04, 2024
Thursday, March 21, 2024
Wednesday, March 20, 2024
Monday, March 18, 2024
- Craig-Hallum Maintains Buy on Fennec Pharmaceuticals, Raises Price Target to $18Benzinga Newsdesk - Mar 18, 2024, 3:31PM
- Fennec Pharmaceuticals shares are trading higher after the company announced that it entered into an exclusive licensing agreement with Norgine to commercialize PEDMARQSI in Europe, Australia and New Zealand.Benzinga Newsdesk - Mar 18, 2024, 11:50AM
- Reported Sunday, Fennec Pharmaceuticals And Norgine Inked An Exclusive Licensing Agreement To Commercialize PEDMARQSI In Europe, Australia, And New ZealandBenzinga Newsdesk - Mar 18, 2024, 2:06AM
Thursday, February 29, 2024
Tuesday, December 05, 2023
Monday, November 06, 2023
- Earnings Scheduled For November 6, 2023Benzinga Insights - Nov 6, 2023, 8:24AM
- Fennec Pharmaceuticals Says Cash And Cash Equivalents Of $12.4M Million Will Be Sufficient To Fund Our Planned Operations For At Least The Next Twelve MonthsBenzinga Newsdesk - Nov 6, 2023, 6:06AM
- Fennec Pharmaceuticals Q3 EPS $(0.07) Beats $(0.11) Estimate, Sales $6.51M Beat $5.42M EstimateBenzinga Newsdesk - Nov 6, 2023, 6:05AM
Friday, November 03, 2023
Wednesday, October 04, 2023
Friday, August 04, 2023
Thursday, August 03, 2023
Wednesday, June 21, 2023
Thursday, May 11, 2023
Wednesday, May 10, 2023
Thursday, April 06, 2023
Tuesday, April 04, 2023
Friday, March 31, 2023
Monday, February 13, 2023
Tuesday, January 31, 2023
Thursday, January 26, 2023
Wednesday, January 25, 2023
Thursday, December 01, 2022
Tuesday, November 22, 2022
- Expert Ratings for Fennec PharmaceuticalsBenzinga Insights - Nov 22, 2022, 3:05PM
- What 4 Analyst Ratings Have To Say About Fennec PharmaceuticalsBenzinga Insights - Nov 22, 2022, 2:01PM
- 4 Analysts Have This to Say About Fennec PharmaceuticalsBenzinga Insights - Nov 22, 2022, 12:02PM
- Where Fennec Pharmaceuticals Stands With AnalystsBenzinga Insights - Nov 22, 2022, 10:04AM
- Cantor Fitzgerald Upgrades Fennec Pharmaceuticals to Overweight, Raises Price Target to $12Benzinga Newsdesk - Nov 22, 2022, 8:25AM
Friday, November 11, 2022
Thursday, October 20, 2022
Monday, October 17, 2022
Monday, September 26, 2022
Thursday, September 22, 2022
Wednesday, September 21, 2022
- After Two FDA Rejections, Fennec Pharma Lead Drug Scores US Approval For Chemo-Induced Hearing LossVandana Singh - Sep 21, 2022, 1:05PM
- Why Adamis Pharmaceuticals Is Trading Lower By Around 44%, Here Are 46 Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Sep 21, 2022, 12:40PM
- Fennec Pharmaceuticals Announces FDA Approval Of PEDMARKBill Haddad - Sep 21, 2022, 7:00AM